
Joshua Joo
Examiner (ID: 11954, Phone: (571)272-3966 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | 2154, 2454, 2445 |
| Total Applications | 1186 |
| Issued Applications | 850 |
| Pending Applications | 94 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5070351
[patent_doc_number] => 20070191453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 11/674011
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12192
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11674011
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/674011 | USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION | Feb 11, 2007 | Abandoned |
Array
(
[id] => 5070359
[patent_doc_number] => 20070191461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE'
[patent_app_type] => utility
[patent_app_number] => 11/673977
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15092
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11673977
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673977 | USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE | Feb 11, 2007 | Abandoned |
Array
(
[id] => 5291034
[patent_doc_number] => 20090023764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/278659
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2470
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023764.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278659 | Use of pyrimidinedione derivative for preventing or treating hepatitis C | Feb 7, 2007 | Issued |
Array
(
[id] => 5120727
[patent_doc_number] => 20070142442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Stabilized pharmaceutical compositions containing a calcium channel blocker'
[patent_app_type] => utility
[patent_app_number] => 11/704122
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6046
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11704122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/704122 | Stabilized pharmaceutical compositions containing a calcium channel blocker | Feb 7, 2007 | Abandoned |
Array
(
[id] => 5100891
[patent_doc_number] => 20070184153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'MULTIPLE ANTIOXIDANT OPTIMAL HEALTH/VETERANS ULTIMATE COMPLETE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/671317
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2944
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184153.pdf
[firstpage_image] =>[orig_patent_app_number] => 11671317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/671317 | Multiple antioxidant optimal health/veterans ultimate complete formulations | Feb 4, 2007 | Issued |
Array
(
[id] => 334356
[patent_doc_number] => 07507768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Antidiabetic formulation and method'
[patent_app_type] => utility
[patent_app_number] => 11/668536
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6480
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668536 | Antidiabetic formulation and method | Jan 29, 2007 | Issued |
Array
(
[id] => 4652205
[patent_doc_number] => 20080039461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Treatment of pain by inhibition of p38 map kinase'
[patent_app_type] => utility
[patent_app_number] => 11/648226
[patent_app_country] => US
[patent_app_date] => 2006-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24086
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11648226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/648226 | Treatment of pain by inhibition of p38 map kinase | Dec 27, 2006 | Abandoned |
Array
(
[id] => 4579840
[patent_doc_number] => 07850953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Composition for the permanent shaping of human hair'
[patent_app_type] => utility
[patent_app_number] => 11/567305
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3417
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/850/07850953.pdf
[firstpage_image] =>[orig_patent_app_number] => 11567305
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/567305 | Composition for the permanent shaping of human hair | Dec 5, 2006 | Issued |
Array
(
[id] => 5057683
[patent_doc_number] => 20070060605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Compositions and methods for inhibiting platelet activation and thrombosis'
[patent_app_type] => utility
[patent_app_number] => 11/595130
[patent_app_country] => US
[patent_app_date] => 2006-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24446
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060605.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595130 | Compositions and methods for inhibiting platelet activation and thrombosis | Nov 7, 2006 | Abandoned |
Array
(
[id] => 4983471
[patent_doc_number] => 20070088030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Aerosol formulations for the inhalation of beta-agonists'
[patent_app_type] => utility
[patent_app_number] => 11/543477
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11665
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11543477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/543477 | Aerosol formulations for the inhalation of beta-agonists | Oct 4, 2006 | Abandoned |
Array
(
[id] => 4994269
[patent_doc_number] => 20070009614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Composition and method for treating hypertension'
[patent_app_type] => utility
[patent_app_number] => 11/520297
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7281
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520297 | Composition and method for treating hypertension | Sep 11, 2006 | Abandoned |
Array
(
[id] => 190960
[patent_doc_number] => 07642271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Argatroban formulation'
[patent_app_type] => utility
[patent_app_number] => 11/510981
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3275
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510981
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510981 | Argatroban formulation | Aug 27, 2006 | Issued |
Array
(
[id] => 4699034
[patent_doc_number] => 20080221218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Receptor'
[patent_app_type] => utility
[patent_app_number] => 12/064032
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6409
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221218.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064032
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064032 | Receptor | Aug 14, 2006 | Abandoned |
Array
(
[id] => 4949909
[patent_doc_number] => 20080306035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Methods and Compositions for Treating Female Infertility Using Clomiphene'
[patent_app_type] => utility
[patent_app_number] => 11/997858
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2551
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306035.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997858 | Methods and Compositions for Treating Female Infertility Using Clomiphene | Aug 1, 2006 | Abandoned |
Array
(
[id] => 141340
[patent_doc_number] => 07691409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Simethicone solid oral dosage form'
[patent_app_type] => utility
[patent_app_number] => 11/460741
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11460741
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/460741 | Simethicone solid oral dosage form | Jul 27, 2006 | Issued |
Array
(
[id] => 5625931
[patent_doc_number] => 20060264436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Method of Treating a Psychotic Disorder'
[patent_app_type] => utility
[patent_app_number] => 11/460775
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9099
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11460775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/460775 | Method of Treating a Psychotic Disorder | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5662166
[patent_doc_number] => 20060252762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Methods for treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/485022
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485022 | Methods for treatment of multiple sclerosis | Jul 10, 2006 | Abandoned |
Array
(
[id] => 9950588
[patent_doc_number] => 08999370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Method to treat and prevent posterior capsule opacification'
[patent_app_type] => utility
[patent_app_number] => 11/913798
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 10785
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11913798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913798 | Method to treat and prevent posterior capsule opacification | May 25, 2006 | Issued |
Array
(
[id] => 5368478
[patent_doc_number] => 20090306037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/919308
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21838
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919308 | Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity | Apr 27, 2006 | Abandoned |
| 11/409359 | Novel direct process | Apr 21, 2006 | Abandoned |